Yenher targets recovery on stronger poultry demand

HLIB also highlighted that the stronger Malaysian ringgit should support manufacturing margins, as around 90% of Yenher’s input costs are denominated in US dollars.

“Beyond 2025, we anticipate a step-change in earnings from the commissioning of new capacities — including the black soldier fly plant in Q1 2026, and expanded biotech feed additives, premix, and complete feed production by June 2026. These expansions, alongside resilient demand fundamentals, will reinforce Yenher’s position as a structural beneficiary of Malaysia’s evolving animal nutrition industry,” the research house said in a note.

Headquartered in Seberang Perai Selatan in Penang, Yenher operates across two main business segments:

• Its manufacturing arm produces premixes, complete feed, formulated products, and biotech feed ingredients primarily serving the poultry and swine sectors.
• Its distribution business supplies feed additives, vitamins, minerals, veterinary pharmaceuticals, vaccines, farm equipment, livestock reproduction products, and companion animal health products.

The company’s customer base spans poultry, swine, ruminants, aquaculture, and pets.

Despite the weaker first half, analysts remain positive on Yenher’s long-term outlook. Capacity expansion, coupled with proactive marketing and strong poultry demand, is expected to position the company for sustainable growth in Malaysia’s animal nutrition industry.